RIG-I activating immunostimulatory RNA boosts the efficacy of anticancer vaccines and synergizes with immune checkpoint blockadeResearch in context

RIG-I activating immunostimulatory RNA boosts the efficacy of anticancer vaccines and synergizes with immune checkpoint blockadeResearch in context

Background: Antibody-mediated targeting of regulatory T cell receptors such as CTLA-4 enhances antitumor immune responses against several cancer entities including malignant melanoma. Yet, therapeutic success in patients remains variable underscoring the need for novel combinatorial approaches. Meth...

Full description

Bibliographic Details
Main Authors:	Simon Heidegger, Diana Kreppel, Michael Bscheider, Florian Stritzke, Tatiana Nedelko, Alexander Wintges, Sarah Bek, Julius C. Fischer, Theresa Graalmann, Ulrich Kalinke, Florian Bassermann, Tobias Haas, Hendrik Poeck
Format:	Article
Language:	English
Published:	Elsevier 2019-03-01
Series:	EBioMedicine
Online Access:	http://www.sciencedirect.com/science/article/pii/S2352396419301355

Similar Items

Targeting intrinsic RIG-I signaling turns melanoma cells into type I interferon-releasing cellular antitumor vaccines
by: Sarah Bek, et al.
Published: (2019-04-01)

Immunostimulatory nanomedicines synergize with checkpoint blockade immunotherapy to eradicate colorectal tumors
by: Xiaopin Duan, et al.
Published: (2019-04-01)

PLGA-particle vaccine carrying TLR3/RIG-I ligand Riboxxim synergizes with immune checkpoint blockade for effective anti-cancer immunotherapy
by: Julia Koerner, et al.
Published: (2021-05-01)

Immunostimulatory and Oncolytic Properties of Rotavirus Can Overcome Resistance to Immune Checkpoint Blockade Therapy
by: Shekarian, Tala
Published: (2017)

Lurbinectedin synergizes with immune checkpoint blockade to generate anticancer immunity
by: Wei Xie, et al.
Published: (2019-11-01)

Proimmunogenic impact of MEK inhibition synergizes with agonist anti-CD40 immunostimulatory antibodies in tumor therapy
by: Daniel Baumann, et al.
Published: (2020-05-01)

Ivermectin converts cold tumors hot and synergizes with immune checkpoint blockade for treatment of breast cancer
by: Dobrin Draganov, et al.
Published: (2021-03-01)

Immunogenic Cell Death Inducing Fluorinated Mitochondria‐Disrupting Helical Polypeptide Synergizes with PD‐L1 Immune Checkpoint Blockade
by: Seong Dong Jeong, et al.
Published: (2021-04-01)

SHP2 inhibition triggers anti-tumor immunity and synergizes with PD-1 blockade
by: Mingxia Zhao, et al.
Published: (2019-03-01)

Immunostimulatory activity of schistosomula in mice
by: Reham A. Abdel Aleem, et al.
Published: (2018-11-01)

Small-cell lung cancer growth inhibition: synergism between NMDA receptor blockade and chemotherapy
by: North WG, et al.
Published: (2019-01-01)

Immunostimulatory Potential of Fruits and Their Extracts in Poultry
by: Teri-Lyn Hasted, et al.
Published: (2021-05-01)

Sunitinib Exerts In Vitro Immunomodulatory Activity on Sarcomas via Dendritic Cells and Synergizes With PD-1 Blockade
by: Darina Ocadlikova, et al.
Published: (2021-02-01)

Elucidating the gut microbiota composition and the bioactivity of immunostimulatory commensals for the optimization of immune checkpoint inhibitors
by: Romain Daillère, et al.
Published: (2020-01-01)

Evaluating the Immunostimulatory Efficacy of Chicken Fusion Cytokines
by: Yen-Ting Wang, et al.
Published: (2019)

Immunostimulatory therapy of frequent respiratory infections in children
by: E. M. Ovsyannikova, et al.
Published: (2015-12-01)

Structure-activity relationship of immunostimulatory effects of phthalates
by: Nielsen Gunnar D, et al.
Published: (2008-10-01)

The immunostimulatory activity of polysaccharides from Glycyrrhiza uralensis
by: Adila Aipire, et al.
Published: (2020-01-01)

The Immunostimulatory Capacity of Nontypeable Haemophilus influenzae Lipooligosaccharide
by: Gabrielle N. Gaultier, et al.
Published: (2017-02-01)

Immunostimulatory properties of mistletoe extracts and their application in oncology
by: Sylwia Wrotek, et al.
Published: (2014-10-01)

Immunostimulatory activity of <it>Stachys mialhesi</it> de Noé
by: Benmebarek Assia, et al.
Published: (2013-01-01)

ANTIVIRAL AND IMMUNOSTIMULATORY POTENTIAL OF FLUORINE CONTAINING TRIAZOLES
by: K. Naumenko, et al.
Published: (2017-09-01)

The anaerobic coryneform bacteria: their microbiological and immunostimulatory properties
by: Russell, R. J.
Published: (1978)

The Immunostimulatory Effects of Dioscorea Tuber Cultivated in Taiwan
by: Cheng-Feng Kuo, et al.
Published: (2009)

Immunostimulatory effect of β-cryptoxanthin in vitro and in vivo
by: Kosuke Nishi, et al.
Published: (2012-07-01)

A poly-neoantigen DNA vaccine synergizes with PD-1 blockade to induce T cell-mediated tumor control
by: Elena Tondini, et al.
Published: (2019-11-01)

Combination Strategies for Immune-Checkpoint Blockade and Response Prediction by Artificial Intelligence
by: Florian Huemer, et al.
Published: (2020-04-01)

Pharmacologial interactions: Synergism, or not synergism, that is the question
by: Luigino Calzetta, et al.
Published: (2021-01-01)

Immune Checkpoint Blockade for Aspergillosis and Mucormycosis Coinfection
by: Jan Christoph Banck, et al.
Published: (2021-03-01)

Immunostimulatory properties of dendritic cells after Leishmania donovani infection using an in vitro model of liver microenvironment.
by: Ludovic Donaghy, et al.
Published: (2010-01-01)

MDM2 inhibitor APG-115 synergizes with PD-1 blockade through enhancing antitumor immunity in the tumor microenvironment
by: Douglas D. Fang, et al.
Published: (2019-11-01)

Combinatorial PD-1 blockade and CD137 activation has therapeutic efficacy in murine cancer models and synergizes with cisplatin.
by: Huafeng Wei, et al.
Published: (2013-01-01)

Blockade of AMPK-Mediated cAMP–PKA–CREB/ATF1 Signaling Synergizes with Aspirin to Inhibit Hepatocellular Carcinoma
by: Hongying Zhang, et al.
Published: (2021-04-01)

Synergism
by: Gustavus, Duane L. (Duane Livingston)
Published: (1972)

An immunostimulatory dual-functional nanocarrier that improves cancer immunochemotherapy
by: Yichao Chen, et al.
Published: (2016-11-01)

Cryptococcus gattii alters immunostimulatory potential in response to the environment.
by: Keigo Ueno, et al.
Published: (2019-01-01)

Impact of treatment schedule on the efficacy of cytostatic and immunostimulatory agents
by: Giulia Petroni, et al.
Published: (2021-01-01)

Trial Watch: Immunostimulatory monoclonal antibodies for oncological indications
by: Mariona Cabo, et al.
Published: (2017-12-01)

On the isolation of immunostimulatory active acemannan from Aloe barbadensis
by: Mabel Alonso, et al.

Regulation of inflammatory gene expression in PBMCs by immunostimulatory botanicals.
by: Karen L Denzler, et al.
Published: (2010-01-01)